Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Toshiya Katayama"'
Autor:
Toshiya Katayama, Hiroaki Matsuda
Publikováno v:
Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan. 141(11)
At small or mid-sized medical institutions, such as Japanese community hospitals, adequate infectious disease physicians (IDP) are lacking, mainly due to shortages of full-time pharmacists and IDPs who support antimicrobial stewardship team (AST) act
Autor:
Masahiro Okuda, Kazuyo Tsukuda, Toshiya Katayama, Masashi Fujita, Toshiaki Ieda, Hiroaki Matsuda, Tetsuro Koide, Yuka Sato, Hideyuki Kuroda
Publikováno v:
Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 37:367-370
Autor:
Takumi UMEMURA, Takahiro MOCHIZUKI, Yuichi MURAKI, Toshiya KATAYAMA, Hisashi TAKI, Norio OHMAGARI, Yuka YAMAGISHI, Hiroshige MIKAMO, Takeshi MORI
Publikováno v:
Japanese Journal of Environmental Infections. 25:376-382
東海地区の55施設においてAnatomical Therapeutic Chemical classification/Defined Daily Dose systemを使用し,注射用抗菌薬の使用量調査を実施し,カルバペネム系薬の使用量とimipenem, meropenemに対する緑膿
Autor:
Sachihiko Numajiri, Tetsushi Sugawa, Kazuya Ooi, Hiromi Sasaki, Naoki Yoshizawa, Yasunori Morimoto, Yasuhide Mizutani, Toshiya Katayama, Saori Kojima, Soichiro Kimura, Hideo Ueda
Publikováno v:
Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 34:1011-1016
We surveyed the current use of lidocaine tape in hemodialysis (HD) patients and evaluated the condition of their skin.Nearly 80% of them complained of pain on needle insertion,and the evaluation of their skin condition indicated that the stratum corn
Autor:
Toshiya Katayama
Publikováno v:
YAKUGAKU ZASSHI. 127:1789-1795
With the revisions to the Japanese medical institutions law of April 2006, an improved medical care security system in a medical institution is indispensable. More and more medical institutions are now assigning full-time pharmacists to the task of m
Autor:
Toshiya Katayama
Publikováno v:
Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan. 135(2)
With the revisions to the pay for performance of pharmaceutical service of inpatients in April 2012, the ward permanent time of pharmacists grew longer than previously; however, there are as yet few reports on the pharmaceutical outcome of the new me
Autor:
Kazuya Ooi, Toshiya Katayama
Publikováno v:
Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 29:300-304
An α-Glucosidase inhibitor, acarbose, offers a novel approach in the treatment of diabetes mellitus. Although several symptoms of the digestive system are known to be side effects of acarbose, severe hepatic disease has also been reported. In this c
Publikováno v:
Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 29:107-110
Clinical pharmacy is now widely performed at Japanese hospitals. Clinical pharmacists are a member of the patient care team and play a new role in pharmacy practice. Drug consultants for doctors as well as counselors for patients also play an importa
Publikováno v:
Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 29:375-378
Acarbose, an α-glucosidase inhibitor, is a well-established treatment of diabetes mellitus. Unfortunately, acarbose has one very frequent side effect, namely increased flatulence, which can interfere with its continuous administration. However, we s
Autor:
Masashi, Fujita, Tetsuro, Koide, Toshiya, Katayama, Hiroaki, Matsuda, Yota, Yamagishi, Masahiro, Okuda, Yasushi, Kataoka
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 36(8)
A postoperative rectum cancer patient with lung metastasis undergoing hemodialysis was treated with mFOLFOX6 therapy. The primary dose of oxaliplatin (L-OHP) ranged from 60 mg/m(2) to 85 mg/m(2), and adverse reactions and serum platinum concentration